E. N. Kharlamova

E. N. Kharlamova

Auto-generated profile, based on publicly available information

E. N. Kharlamova


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2024 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
ЕВЕ. Н. Воркель
Е. Н. Воркель
Tatiana Magomedalievna ReshetnyakTatiana Magomedalievna Reshetnyak
Tatiana Magomedalievna Reshetnyak
KNK. S. Nurbaeva
K. S. Nurbaeva
MCMARIA CHERKASOVA
MARIA CHERKASOVA
GTG. M. Tarasova
G. M. Tarasova
ALAleksandr M Lila
Aleksandr M Lila
Antineutrophil cytoplasmic antibody-associated systemic vasculitis (ANCA-SV) is a group of rare and potentially severe systemic diseases. The search for reliable methods to assess ANCA-SV activity remains relevant. Among the indicators of neutrophil activation that have emerged in clinical practice, the level of serum calprotectin (CLP) stands out, which can be a marker for monitoring vasculitis activity and identifying patients at risk of disease relapse. Objective: to determine serum CLP levels in patients with ANCA-SV. Material and methods. The study group comprised 64 patients (37 with granulomatosis with polyangiitis, 11 with eosinophilic granulomatosis with polyangiitis and 16 with microscopic polyangiitis) aged 18 years and older with a confirmed diagnosis of ANCA-SV. The control group consisted of 30 healthy individuals. ANCA-SV activity was determined using the BVAS index; high activity corresponded to a BVAS value of >3. Damage was assessed using the VDI index. Depending on ANCA-SV activity, patients were divided into two groups: high activity group (group 1, n=33) and low activity group (group 2, n=31). In addition to the generally accepted indicators, serum CLP levels were assessed in all patients with ANCA-SV and healthy donors. Results and discussion. Statistically significant differences (p<0.001) were found in CLP levels in patients with ANCA-SV in groups 1 and 2. A significant correlation was found between CLP concentration and leukocyte count, neutrophil count, neutrophil-to-lymphocyte ratio (NLR) and systemic inflammatory index (SII). Blood CLP levels in ANCA-SV were associated with creatinine levels and not with glomerular filtration rate and urinary sediment. Although CLP concentration depended on disease activity, it did not correlate with acute phase indicators, including ESR and CRP concentration. Conclusion. Serum CLP concentration is significantly higher in patients with active ANCA-SV and is related to NLR and SII inflammatory indices, so we consider the possibility of using this indicator to assess disease activity.

18 October 2022 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
MEM. S. Eliseev
M. S. Eliseev
EKE. N. Kharlamova
E. N. Kharlamova
OZO. V. Zhelyabina
O. V. Zhelyabina
ALAleksandr M Lila
Aleksandr M Lila
The gut microbiota plays a key role in metabolism and immune regulation, and imbalance in microbial composition can contribute to various diseases. We present up-to-date data on the role of the gut microbiota in the occurrence of chronic hyperuricemia (HU) and gout, which is associated with the influence of the microbiota on the synthesis of purine-metabolizing enzymes and pro-inflammatory cytokines. It has been shown that the gut microbiota plays an important role in the pathophysiology of gout and can serve as a new target for therapy. Currently, the microbial index of gout is considered as a potential method for early diagnosis of the disease, possibly already at the preclinical stage. The gut microbiota can be a starting point in the study of the pathogenesis of HU and gout. This makes it necessary to assess the pathogenetic relationship between individual specific microorganisms, the microbiota as a whole, and the development of uric acid (UA) metabolism disorders that contribute to the onset of HU and its transformation into gout. It is assumed that this approach will provide a more complete understanding of the gut microbiota participation in the synthesis of UA and its extrarenal excretion, as well as of bacteria and bacterial enzymes that can be used as a probiotic coadjuvant for the treatment and prevention of gout.

22 April 2023 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
EKE. N. Kharlamova
E. N. Kharlamova
Tatiana Magomedalievna ReshetnyakTatiana Magomedalievna Reshetnyak
Tatiana Magomedalievna Reshetnyak
GTG. M. Tarasova
G. M. Tarasova
The article presents a review of current data on arteriovenous thrombosis risk factors in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Thrombotic complications are among the most frequent prognostically unfavorable factors in AAV. In general, patients with AAV are at greater risk of mortality from cardiovascular events compared with the general population and patients with other forms of systemic vasculitis. Understanding the mechanisms of thrombosis, as well as pathogenic factors that cause an increased risk of arterial and venous thrombosis in AAV, can improve the quality of management of these patients. Therefore, the question of the need for primary and secondary prevention of thrombosis in AAV is of great practical importance. The presented data show the need to estimate the probability of thrombosis in patients with AAV, taking into account risk factors, as well as the influence of the disease itself and ongoing therapy. Assessment of the risk of thrombosis (both venous and arterial) is necessary for the timely administration of adequate preventive treatment of thrombotic complications in AAV.

28 August 2025 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
Tatiana Magomedalievna ReshetnyakTatiana Magomedalievna Reshetnyak
Tatiana Magomedalievna Reshetnyak
ЕВЕ. Н. Воркель
Е. Н. Воркель
KNK. S. Nurbayeva
K. S. Nurbayeva
ALAleksandr M Lila
Aleksandr M Lila
This literature review addresses the epidemiology, genetic markers, pathogenesis, clinical features, and diagnostic approaches of granulomatosis with polyangiitis and microscopic polyangiitis – both antineutrophil cytoplasmic antibody-associated vasculitides. Particular attention is paid to the role of neutrophil activation and the alternative complement pathway in disease development. The review also includes information on avacopan, an orally administered, selective C5a receptor (C5aR1) inhibitor that blocks the C5a complement component signaling pathway.

22 April 2023 in Modern Rheumatology Journal
Verified
Journal Article
Open access
PDF file
OEO. N. Egorova
O. N. Egorova
EKE. N. Kharlamova
E. N. Kharlamova
GTG. M. Tarasova
G. M. Tarasova
Granulomatosis with polyangiitis (GPA) is a primary vasculitis associated with antineutrophil cytoplasmic antibodies, characterized by necrotizing vasculitis with predominant involvement of small vessels of various localization and necrotizing granulomatous inflammation with multiple clinical manifestations. GPA remains one of the most severe and prognostically unfavorable systemic vasculitis. The second part of the article presents data on the differential diagnosis of the onset of the disease with the ocular and ear involvement, which requires an interdisciplinary approach and interaction between doctors of different specialties. In the refractory course of the local form of GPA, immunosuppressive therapy, including glucocorticoids and rituximab or cyclophosphamide, is advisable.

31 May 2021 in The Russian Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
VDV. V. Didenko
V. V. Didenko
GKG. A. Kalashnik
G. A. Kalashnik
JKJu. Ju. Karpenko
Ju. Ju. Karpenko
EHE. N. Harlamova
E. N. Harlamova
This article considers the relevance of treating psoriatic arthritis with genetically engineered drugs such as adalimumab and secukinumab. Also, it conducts retrospective analysis of the medical history of the patient, who had this therapy.